Measuring Quality of Life in Chronic Limb-threatening Ischemia Patients and Informal Carers: A Scoping Review.
Journal
Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354
Informations de publication
Date de publication:
01 11 2022
01 11 2022
Historique:
pubmed:
9
7
2022
medline:
12
10
2022
entrez:
8
7
2022
Statut:
ppublish
Résumé
To review quality of life (QOL) instruments for chronic limb-threatening ischemia (CLTI) patients and informal carers, and their use in QOL and cost-utility analysis (CUA) studies. CLTI is a global health problem with significant morbidity affecting patients and informal carers. QOL is increasingly measured for holistic outcomes assessment and CUA. However, measurement instruments in CLTI are poorly understood. MEDLINE, EMBASE, PsycINFO, CINAHL, COSMIN, PROQOLID, CEA registry, and NHS EED databases were searched for all English language studies up to May 2021. Features of instruments, evidence of measurement property appraisal, and trends in use were assessed. Prospective protocol registration (Open Science Framework: https://doi.org/10.17605/OSF.IO/KNG9U ). A total of 146 studies on QOL instruments (n=43), QOL outcomes (n=97), and CUA (n=9) were included. Four disease-specific QOL instruments are available for lower extremity arterial disease (intermittent claudication or CLTI). VascuQoL-25 and VascuQoL-6 have been used in CLTI. There is no CLTI-specific instrument. Of 14 generic instruments, SF-36, EQ-5D-3L, NHP, and WHOQOL-BREF were most common. Studies reporting partial measurement property appraisal favored VascuQoL-25, VascuQoL-6, and SF-36. Feasibility considerations include mode of administration and responder burden. None of 4 available carer-specific instruments have been used in CLTI. Since 1992, the number of QOL studies has increased considerably, but CUA studies are scarce. Informal carers have not been assessed. This review provides a comprehensive reference for QOL measurement in CLTI that helps end-users with instrument selection, use, and interpretation. However, a CLTI-specific instrument is needed. There is an opportunity to benefit society through future CUA studies and evaluation of QOL in informal carers.
Sections du résumé
OBJECTIVE
To review quality of life (QOL) instruments for chronic limb-threatening ischemia (CLTI) patients and informal carers, and their use in QOL and cost-utility analysis (CUA) studies.
BACKGROUND
CLTI is a global health problem with significant morbidity affecting patients and informal carers. QOL is increasingly measured for holistic outcomes assessment and CUA. However, measurement instruments in CLTI are poorly understood.
METHODS
MEDLINE, EMBASE, PsycINFO, CINAHL, COSMIN, PROQOLID, CEA registry, and NHS EED databases were searched for all English language studies up to May 2021. Features of instruments, evidence of measurement property appraisal, and trends in use were assessed. Prospective protocol registration (Open Science Framework: https://doi.org/10.17605/OSF.IO/KNG9U ).
RESULTS
A total of 146 studies on QOL instruments (n=43), QOL outcomes (n=97), and CUA (n=9) were included. Four disease-specific QOL instruments are available for lower extremity arterial disease (intermittent claudication or CLTI). VascuQoL-25 and VascuQoL-6 have been used in CLTI. There is no CLTI-specific instrument. Of 14 generic instruments, SF-36, EQ-5D-3L, NHP, and WHOQOL-BREF were most common. Studies reporting partial measurement property appraisal favored VascuQoL-25, VascuQoL-6, and SF-36. Feasibility considerations include mode of administration and responder burden. None of 4 available carer-specific instruments have been used in CLTI. Since 1992, the number of QOL studies has increased considerably, but CUA studies are scarce. Informal carers have not been assessed.
CONCLUSIONS
This review provides a comprehensive reference for QOL measurement in CLTI that helps end-users with instrument selection, use, and interpretation. However, a CLTI-specific instrument is needed. There is an opportunity to benefit society through future CUA studies and evaluation of QOL in informal carers.
Identifiants
pubmed: 35801704
doi: 10.1097/SLA.0000000000005477
pii: 00000658-202211000-00039
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e331-e341Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Nehler MR, Duval S, Diao L, et al. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg. 2014;60:686–695.e2.
Song P, Rudan D, Zhu Y, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7:e1020–e1030.
Duff S, Mafilios MS, Bhounsule P, et al. The burden of critical limb ischemia: a review of recent literature. Vasc Health Risk Manag. 2019;15:187–208.
Williams K, Sansoni J, Morris D, et al. Patient-reported outcome measures: Literature review. Australian Commission on Safety and Quality in Health Care 2016. Available at: https://www.safetyandquality.gov.au/our-work/indicators-measurement-and-reporting/patient-reported-outcomes/evidence-proms . Accessed May 3, 2021.
Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford, Oxford: Oxford University Press; 2015
Vissapragada R, Bulamu N, Karnon J, et al. Cost-effectiveness in surgery: concepts of cost-utility analysis explained. ANZ J Surg. 2021;91:1717–1723.
Pennington BM. Inclusion of carer health-related quality of life in National Institute for Health and Care Excellence Appraisals. Value Health. 2020;23:1349–1357.
Australian Institute of Health and Welfare. Informal carers. 2019. Available at: https://www.aihw.gov.au/reports/australias-welfare/informal-carers . Accessed May 20, 2021.
Goodrich K, Kaambwa B, Al-Janabi H. The inclusion of informal care in applied economic evaluation: a review. Value Health. 2012;15:975–981.
Tur-Sinai ATA, Rommel A, Hlebec V, et al. How many older informal caregivers are there in Europe? Comparison of estimates of their prevalence from three European surveys. Int J Environ Res Public Health. 2020;17:9531.
American Association of Retired Persons and National Alliance for Caregiving. Caregiving in the United States 2020. Washington, DC: AARP; 2020. Available at: https://doi.org/10.26419/ppi.00103.001 .
Mofidi R, Wong P, Gatenby T, et al. Value based healthcare and delivery of vascular surgery services in the United Kingdom. Rev Vasc Med. 2016;6:1–9.
Xu J, Prince AER. Shared decision-making in vascular surgery. J Vasc Surg. 2019;70:1711–1715.
Aromataris E, Munn Z. eds. JBI Manual for Evidence Synthesis. JBI, 2020. Available at: https://synthesismanual.jbi.global ; https://doi.org/10.46658/JBIMES-20-01 .
Munn Z, Peters MDJ, Stern C, et al. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18:143.
Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467–473.
Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1S):S1–S109 e33.
Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics. 2016;34:645–649.
Testa MA, Simonson DC. Assesment of quality-of-life outcomes. N Engl J Med. 1996;334:835–840.
Sperber AD. Translation and validation of study instruments for cross-cultural research. Gastroenterology. 2004;126(sppl 1):S124–S128.
McKeown S, Mir ZM. Considerations for conducting systematic reviews: evaluating the performance of different methods for de-duplicating references. Syst Rev. 2021;10:38.
Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622–629.
Lorente S, Viladrich C, Vives J, et al. Tools to assess the measurement properties of quality of life instruments: a meta-review. BMJ Open. 2020;10:e036038.
Ryan TP. Statistical Methods for Quality Improvement, 3rd ed. Hoboken, New Jersey: Wiley; 2011.
Abidia A, Laden G, Kuhan G, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomized-controlled trial. Eur J Vasc Endovasc Surg. 2003;25:513–518.
Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–1934.
Aitken E, McColl G, Kingsmore D. The Role of Qutenza R (Topical Capsaicin 8%) in treating neuropathic pain from critical ischemia in patients with end-stage renal disease: an observational cohort study. Pain Med. 2017;18:330–340.
Albers M, Fratezi AC, De Luccia N. Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease. J Vasc Surg. 1992;16:54–59.
Albers M, Fratezi AC, De Luccia N. Walking ability and quality of life as outcome measures in a comparison of arterial reconstruction and leg amputation for the treatment of vascular disease. Eur J Vasc Endovasc Surg. 1996;11:308–314.
Barshes NR, Chambers JD, Cohen J, et al. Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss. J Vasc Surg. 2012;56:1015–1024.e1.
Belowski A, Partyka L, Krzanowski M, et al. Clinical and linguistic validation of the Polish version of VascuQol: a disease-specific quality-of-life questionnaire assessing patients with chronic limb ischemia. Polish Arch Intern Med. 2019;129:167–174.
Berceli SA, Hevelone ND, Lipsitz SR, et al. Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J Vasc Surg. 2007;46:1173–1179.
Bradbury AW, Adam DJ, Bell J, et al. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial. Health Technology Assessment (Winchester, England). 2010;14:1–210; iii.
Brothers TE, Rios GA, Robison JG, et al. Justification of intervention for limb-threatening ischemia: a surgical decision analysis. Cardiovasc Surg. 1999;7:62–69.
Brummer U, Condini V, Cappelli P, et al. Spinal cord stimulation in hemodialysis patients with critical lower-limb ischemia. Am J Kidney Dis. 2006;47:842–847.
Bruni KR, Hoosier-Paty DM, Hoffman GT. The quality of life of the limb-threatened patient after lower-extremity revascularization … presented at the 14th National Symposium of the Society for Vascular Nursing, June 14, 1996, New Orleans, Louisiana. J Vasc Nurs. 1996;14:99–103.
Chetter IC, Dolan P, Spark JI, et al. Correlating clinical indicators of lower-limb ischaemia with quality of life. Cardiovasc Surg. 1997;5:361–366.
Chetter IC, Spark JI, Dolan P, et al. Quality of life analysis in patients with lower limb ischaemia: suggestions for European standardisation. Eur J Vasc Endovasc Surg. 1997;13:597–604.
Chetter IC, Spark JI, Scott DJ, et al. Prospective analysis of quality of life in patients following infrainguinal reconstruction for chronic critical ischaemia. Br J Surg. 1998;85:951–955.
Chochola M, Pytlik R, Kobylka P, et al. Autologous intra-arterial infusion of bone marrow mononuclear cells in patients with critical leg ischemia. Int Angiol. 2008;27:281–290.
Conijn AP, Santema TB, Bipat S, et al. Clinimetric evaluation of the vascular quality of life questionnaire in patients with lower limb ischaemia. Eur J Vasc Endovasc Surg. 2017;53:412–418.
Corriere MA, Goldman MP, Barnard R, et al. Cumulative number of treatment interventions predicts health-related quality of life in patients with critical limb ischemia. Ann Vasc Surg. 2017;44:41–47.
Cruz Silva J, Constancio Oliveira V, Lima P, et al. Change in domains that influence quality of life after major lower limb amputation in patients with peripheral arterial disease. Ann Vasc Surg. 2021;05:05.
Culverwell AD, Tapping CR, Ettles DF, et al. Patient experience, pain, and quality of life after lower limb angioplasty: a multisite prospective cohort study. Cardiovasc Intervent Radiol. 2012;35:788–794.
de Vries M, Ouwendijk R, Kessels AG, et al. Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease. J Vasc Surg. 2005;41:261–268.
Deutschmann HA, Schoellnast H, Temmel W, et al. Endoluminal therapy in patients with peripheral arterial disease: prospective assessment of quality of life in 190 patients. AJR Am J Roentgenol. 2007;188:169–175.
Drelicharz L, Belowski A, Krzanowski M, et al. Safety and efficacy of endovascular treatment of chronic ischemia of the lower limbs in 6-months follow-up. [Polish, English]. Acta Angiologica. 2013;19:13–35.
Dua A, Rothenberg KA, Lee JJ, et al. Six-month freedom from amputation rates and quality of life following tibial and pedal endovascular revascularization for critical limb ischemia. Vasc Endovascular Surg. 2019;53:212–215.
Engelhardt M, Bruijnen H, Scharmer C, et al. Improvement of quality of life six months after infrageniculate bypass surgery: diabetic patients benefit less than non-diabetic patients. Eur J Vasc Endovasc Surg. 2006;32:182–187.
Engelhardt M, Bruijnen H, Scharmer C, et al. Prospective 2-years follow-up quality of life study after infrageniculate bypass surgery for limb salvage: lasting improvements only in non-diabetic patients. Eur J Vasc Endovasc Surg. 2008;36:63–70.
Forbes JF, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis. J Vasc Surg. 2010;51(suppl):43S–51S.
Frans FA, Met R, Koelemay MJ, et al. Changes in functional status after treatment of critical limb ischemia. J Vasc Surg. 2013;58:957–965 e1.
Frans FA, Nieuwkerk PT, Met R, et al. Statistical or clinical improvement? Determining the minimally important difference for the vascular quality of life questionnaire in patients with critical limb ischemia. Eur J Vasc Endovasc Surg. 2014;47:180–186.
Fratezi AC, Albers M, De Luccia N, et al. Outcome and quality of life of patients with severe chronic limb ischaemia: a cohort study on the influence of diabetes. Eur J Vasc Endovasc Surg. 1995;10:459–465.
Fukuhara S, Esato K. The effect of Liple on physical and emotional quality of life in the treatment of arteriosclerosis obliterans. Int Angiol. 2004;23:238–245.
Garcia L, Jaff M, Rocha-Singh K, et al. Acute results of directional atherectomy for the treatment of claudication and critical limb ischemia in the DEFINITIVE le study. Vasc Dis Manage. 2017;14:E21–E33.
Giannopoulos S, Mustapha J, Gray WA, et al. Three-year outcomes from the LIBERTY 360 study of endovascular interventions for peripheral artery disease stratified by Rutherford category. J Endovasc Ther. 2021;28:262–274.
Hallin A, Bergqvist D, Fugl-Meyer K, et al. Areas of concern, quality of life and life satisfaction in patients with peripheral vascular disease. Eur J Vasc Endovasc Surg. 2002;24:255–263.
Hernandez-Osma E, Cairols MA, Marti X, et al. Impact of treatment on the quality of life in patients with critical limb ischaemia. Eur J Vasc Endovasc Surg. 2002;23:491–494.
Holler D, Claes C, Von Der Schulenburg JM. Treatment costs and quality of life of patients with peripheral arterial occlusive disease—The German perspective. VASA. 2004;33:145–153.
Hoshino J, Ubara Y, Hara S, et al. Quality of life improvement and long-term effects of peripheral blood mononuclear cell transplantation for severe arteriosclerosis obliterans in diabetic patients on dialysis. Circ J. 2007;71:1193–1198.
Humphreys WV, Evans F, Watkin G, et al. Critical limb ischaemia in patients over 80 years of age: options in a district general hospital. Br J Surg. 1995;82:1361–1363.
Hunink MG, Wong JB, Donaldson MC, et al. Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA. 1995;274:165–171.
Iida O, Takahara M, Soga Y, et al. Prognostic impact of revascularization in poor-risk patients with critical limb ischemia: the PRIORITY Registry (Poor-Risk Patients With and Without Revascularization Therapy for Critical Limb Ischemia). JACC Cardiovasc Interv. 2017;10:1147–1157.
Ikeda S, Kobayashi M, Fukuhara S, et al. Cost-effectiveness of Liple (LipoPGE1) for arteriosclerosis obliterans patients in Japan: an economic evaluation using the EQ-5D instrument. Int Angiol. 2006;25:169–174.
Jens S, Conijn AP, Frans FA, et al. Outcomes of infrainguinal revascularizations with endovascular first strategy in critical limb ischemia. Cardiovasc Intervent Radiol. 2015;38:552–559.
Johnson BF, Evans L, Drury R, et al. Surgery for limb threatening ischaemia: a reappraisal of the costs and benefits. Eur J Vasc Endovasc Surg. 1995;9:181–188.
Johnson BF, Singh S, Evans L, et al. A prospective study of the effect of limb-threatening ischaemia and its surgical treatment on the quality of life. Eur J Vasc Endovasc Surg. 1997;13:306–314.
Kalbaugh CA, Taylor SM, Blackhurst DW, et al. One-year prospective quality-of-life outcomes in patients treated with angioplasty for symptomatic peripheral arterial disease. J Vasc Surg. 2006;44:296–302; discussion 302.
Kalbaugh CA, Taylor SM, Cull DL, et al. Invasive treatment of chronic limb ischemia according to the Lower Extremity Grading System (LEGS) score: a 6-month report. J Vasc Surg. 2004;39:1268–1276.
Kearns BC, Michaels JA, Stevenson MD, et al. Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease. Br J Surg. 2013;100:1180–1188.
Keeling AN, Naughton PA, O’Connell A, et al. Does percutaneous transluminal angioplasty improve quality of life? J Vasc Interv Radiol. 2008;19(pt 1):169–176.
Khalil E, Ozcan S. Health-related quality of life after vascular surgery and endovascular treatment in subjects with critical limb ischemia. Pak J Med Sci. 2020;36:877–883.
Klepanec A, Mistrik M, Altaner C, et al. No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia. Cell Transplant. 2012;21:1909–1918.
Klevsgard R, Froberg BL, Risberg B, et al. Nottingham Health Profile and Short-Form 36 Health Survey questionnaires in patients with chronic lower limb ischemia: before and after revascularization. J Vasc Surg. 2002;36:310–317.
Klevsgard R, Hallberg IR, Risberg B, et al. Quality of life associated with varying degrees of chronic lower limb ischaemia: comparison with a healthy sample. Eur J Vasc Endovasc Surg. 1999;17:319–325.
Klevsgard R, Hallberg IR, Risberg B, et al. The effects of successful intervention on quality of life in patients with varying degrees of lower-limb ischaemia. Eur J Vasc Endovasc Surg. 2000;19:238–245.
Klevsgard R, Risberg BO, Thomsen MB, et al. A 1-year follow-up quality of life study after hemodynamically successful or unsuccessful surgical revascularization of lower limb ischemia. J Vasc Surg. 2001;33:114–122.
Kumar BN, Gambhir RP. Critical limb ischemia-need to look beyond limb salvage. Ann Vasc Surg. 2011;25:873–877.
Kumlien C, Nordanstig J, Lundstrom M, et al. Validity and test retest reliability of the vascular quality of life Questionnaire-6: a short form of a disease-specific health-related quality of life instrument for patients with peripheral arterial disease. Health Qual Life Outcomes. 2017;15:187.
Kusumanto YH, van Weel V, Mulder NH, et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther. 2006;17:683–691.
Landry GJ, Esmonde NO, Lewis JR, et al. Objective measurement of lower extremity function and quality of life after surgical revascularization for critical lower extremity ischemia. J Vasc Surg. 2014;60:136–142.
Larsen ASF, Reiersen AT, Jacobsen MB, et al. Validation of the Vascular quality of life questionnaire—6 for clinical use in patients with lower limb peripheral arterial disease. Health Qual Life Outcomes. 2017;15:184.
Lasala GP, Silva JA, Minguell JJ. Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product. J Thorac Cardiovasc Surg. 2012;144:377–382.
Lindgren H, Gottsater A, Qvarfordt P, et al. All cause chronic widespread pain is common in patients with symptomatic peripheral arterial disease and is associated with reduced health related quality of life. Eur J Vasc Endovasc Surg. 2016;52:205–210.
Maksimovic M, Vlajinac H, Marinkovic J, et al. Health-related quality of life among patients with peripheral arterial disease. Angiology. 2014;65:501–506.
McGillicuddy EA, Ozaki CK, Shah SK, et al. The impact of vascular surgery wound complications on quality of life. J Vasc Surg. 2016;64:1780–1788.
McKinsey JF, Zeller T, Rocha-Singh KJ, et al. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv. 2014;7:923–933.
Murphy MP, Lawson JH, Rapp BM, et al. Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. J Vasc Surg. 2011;53:1565–74.e1.
Mustapha J, Gray W, Martinsen BJ, et al. One-year results of the LIBERTY 360 study: evaluation of acute and midterm clinical outcomes of peripheral endovascular device interventions. J Endovasc Ther. 2019;26:143–154.
Mustapha JA, Igyarto Z, O’Connor D, et al. One-year outcomes of peripheral endovascular device intervention in critical limb ischemia patients: sub-analysis of the LIBERTY 360 study. Vasc Health Risk Manage. 2020;16:57–66.
Nguyen LL, Brahmanandam S, Bandyk DF, et al. Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg. 2007;46:1191–1197.
Nguyen LL, Moneta GL, Conte MS, et al. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg. 2006;44:977–983; discussion 983.
Nordanstig J, Karlsson J, Pettersson M, et al. Psychometric properties of the disease-specific health-related quality of life instrument VascuQoL in a Swedish setting. Health & Quality of Life Outcomes. 2012;10:45.
Nordanstig J, Pettersson M, Morgan M, et al. Assessment of minimum important difference and substantial clinical benefit with the Vascular Quality of Life Questionnaire-6 when evaluating revascularisation procedures in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2017;54:340–347.
Nordanstig J, Wann-Hansson C, Karlsson J, et al. Vascular Quality of Life Questionnaire-6 facilitates health-related quality of life assessment in peripheral arterial disease. J Vasc Surg. 2014;59:700–707.
Palena LM, Diaz-Sandoval LJ, Sultato E, et al. Feasibility and 1-year outcomes of subintimal revascularization with supera stenting of long femoropopliteal occlusions in critical limb ischemia: the “Supersub” Study. Catheter Cardiovasc Interv. 2017;89:910–920.
Pell JP, Donnan PT, Fowkes FG, et al. Quality of life following lower limb amputation for peripheral arterial disease. Eur J Vasc Surg. 1993;7:448–451.
Perin EC, Silva G, Gahremanpour A, et al. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2011;78:1060–1067.
Peters CM, de Vries J, Veen EJ, et al. Is amputation in the elderly patient with critical limb ischemia acceptable in the long term? Clin Interv Aging. 2019;14:1177–1185.
Peters CML, de Vries J, Lodder P, et al. Quality of life and not health status improves after major amputation in the elderly critical limb ischaemia patient. Eur J Vasc Endovasc Surg. 2019;57:547–553.
Peters CML, de Vries J, Lodder P, et al. Is a good quality of life and health status possible in older patients dying from critical limb-threatening ischemia: a prospective clinical study. Ann Vasc Surg. 2020;64:198–201.
Peters CML, de Vries J, Redeker S, et al. Cost-effectiveness of the treatments for critical limb ischemia in the elderly population. J Vasc Surg. 2019;70:530–538 e1.
Peters CML, Lodder P, de Vries J, et al. Two-year outcome of quality of life and health status for the elderly with chronic limb-threatening ischemia. Clin Interv Aging. 2020;15:2383–2395.
Pisa G, Reinhold T, Obi-Tabot E, et al. Critical limb ischemia and its impact on patient health preferences and quality of life-an international study. Int J Angiol. 2012;21:139–146.
Quigley M, Dillon MP, Duke EJ. Comparison of quality of life in people with partial foot and transtibial amputation: a pilot study. Prosthet Orthot Int. 2016;40:467–474.
Raval AN, Schmuck EG, Tefera G, et al. Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial. Cytotherapy. 2014;16:1720–1732.
Remes L, Isoaho R, Vahlberg T, et al. Quality of life three years after major lower extremity amputation due to peripheral arterial disease. Aging Clin Exp Res. 2010;22:395–405.
Rocha-Neves J, Ferreira A, Pereira-Neves A, et al. The peripheral artery questionnaire validation of the Portuguese version. Rev Port Cir Cardiotorac Vasc. 2020;27:23–31.
Roijers JP, van den Houten MM, Hopmans NJ, et al. A comparison of quality of life in elderly patients with intermittent claudication and chronic limb-threatening ischemia. Ann Vasc Surg. 2020;69:285–291.
Sasajima T, Sasajima Y, Akazawa K, et al. Arterial reconstruction for patients with chronic limb ischemia improves ambulatory function and health-related quality of life. Ann Vasc Surg. 2020;66:518–528.
Schulte KL, Hardung D, Tiefenbacher C, et al. Real-world outcomes of endovascular treatment in a non-selected population with peripheral artery disease - prospective study with 2-year follow-up. Vasa. 2019;48:433–441.
Shechter M, Auslander G, Weinmann EE, et al. Quality of life and social support following distal arterial bypass in elderly patients. Isr Med Assoc J. 2003;5:322–325.
Shigematsu H, Yasuda K, Iwai T, et al. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther. 2010;17:1152–1161.
Sipahioglu NT, Arslan C, Can G, et al. Factors affecting quality of life after bypass grafting in critical leg ischemia. Nobel Medicus. 2017;13:52–56.
Slovacek L, Slovackova B, Chovanec V, et al. Quality of life and arterial endovascular intervention by means of balloon angioplasty. Int Angiol. 2008;27:396–400.
Slovacek L, Slovakova B, Chovanec V, et al. The effect of selected health, demographic and psychosocial aspects on quality of life in patients with peripheral arterial occlusive disease—a prospective analysis. Acta Medica (Hradec Kralove). 2007;50:125–127.
Smith AD, Hawkins AT, Schaumeier MJ, et al. Predictors of major amputation despite patent bypass grafts. J Vasc Surg. 2016;63:1279–1288.
Spertus J, Jones P, Poler S, et al. The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease. Am Heart J. 2004;147:301–308.
Spincemaille GH, Klomp HM, Steyerberg EW, et al. Pain and quality of life in patients with critical limb, ischaemia: results of a randomized controlled multicentre study on the effect of spinal cord stimulation. Eur J Pain. 2000;4:173–184.
Sprengers RW, Teraa M, Moll FL, et al. Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment. J Vasc Surg. 2010;52:843–849.e1.
Steunenberg SL, de Vries J, Raats JW, et al. Quality of life and mortality after endovascular, surgical, or conservative treatment of elderly patients suffering from critical limb ischemia. Ann Vasc Surg. 2018;51:95–105.
Steunenberg SL, de Vries J, Raats JW, et al. Important differences between quality of life and health status in elderly patients suffering from critical limb ischemia. Clin Interv Aging. 2019;14:1221–1226.
Steunenberg SL, de Vries J, Raats JW, et al. Quality of life and traditional outcome results at 1 year in elderly patients having critical limb ischemia and the role of conservative treatment. Vasc Endovascular Surg. 2020;54:126–134.
Teichgraber U, Lehmann T, Thieme M, et al. Drug-coated balloon angioplasty of infrapopliteal lesions in patients with critical limb ischaemia: 1-year results of the APOLLO Trial. Cardiovasc Intervent Radiol. 2019;42:1380–1390.
Thorsen H, McKenna S, Tennant A, et al. Nottingham health profile scores predict the outcome and support aggressive revascularisation for critical ischaemia. Eur J Vasc Endovasc Surg. 2002;23:495–499.
Tolva VS, Casana R, Lonati L, et al. Percutaneous transluminal angioplasty improves glucose control and quality of life in patients with critical limb ischemia. Eur Rev Med Pharmacol Sci. 2012;16:2082–2087.
Torbjornsson E, Ottosson C, Bostrom L, et al. Health-related quality of life and prosthesis use among patients amputated due to peripheral arterial disease - a one-year follow-up. Disabil Rehabil. 2020;25:1–9.
Treat-Jacobson D, Lindquist RA, Witt DR, et al. The PADQOL: development and validation of a PAD-specific quality of life questionnaire. Vasc Med. 2012;17:405–415.
Tretinyak AS, Lee ES, Kuskowski MA, et al. Revascularization and quality of life for patients with limb-threatening ischemia. Ann Vasc Surg. 2001;15:84–88.
Tshomba Y, Psacharopulo D, Frezza S, et al. Predictors of improved quality of life and claudication in patients undergoing spinal cord stimulation for critical lower limb ischemia. Ann Vasc Surg. 2014;28:628–632.
Turner AP, Wegener ST, Williams RM, et al. Self-management to improve function following amputation: a randomized controlled trial of the VETPALS intervention. Arch Phys Med Rehabil. 2021;102:1274–1282.
Villemoes MK, Lindholt JS, Houlind KC, et al. Cost-effectiveness evaluation of heparin coated versus standard graft for bypass surgery in peripheral artery disease alongside a randomised controlled trial. Eur J Vasc Endovasc Surg. 2018;56:87–93.
Virkkunen J, Venermo M, Saarinen J, et al. Impact of endovascular treatment on clinical status and health-related quality of life. Scand J Surg. 2008;97:50–55.
Wachsmann A, Maga M, Schonborn M, et al. Impact of pre-operative glycated haemoglobin A1C level on 1-year outcomes of endovascular treatment in patients with critical limb ischemia in the course of diabetes mellitus. Folia Med Cracov. 2019;59:49–60.
Wang SK, Green LA, Gutwein AR, et al. Ethnic minorities with critical limb ischemia derive equal amputation risk reduction from autologous cell therapy compared with whites. J Vasc Surg. 2018;68:560–566.
Wann-Hansson C, Hallberg IR, Risberg B, et al. A comparison of the Nottingham Health Profile and Short Form 36 Health Survey in patients with chronic lower limb ischaemia in a longitudinal perspective. Health Qual Life Outcomes. 2004;2:9.
Wann-Hansson C, Hallberg IR, Risberg B, et al. Health-related quality of life after revascularization for peripheral arterial occlusive disease: long-term follow-up. J Adv Nurs. 2005;51:227–235.
Al-Janabi H, Coast J, Flynn TN. What do people value when they provide unpaid care for an older person? A meta-ethnography with interview follow-up. Soc Sci Med. 2008;67:111–121.
Al-Janabi H, Flynn TN, Coast J. Estimation of a preference-based carer experience scale. Med Decis Making. 2011;31:458–468.
Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–292.
Brazier JE, Mulhern BJ, Bjorner JB, et al. Developing a new version of the SF-6D Health State Classification System from the SF-36v2: SF-6Dv2. Med Care. 2020;58:557–565.
Brouwer WB, van Exel NJ, van Gorp B, et al. The CarerQol instrument: a new idnstrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual Life Res. 2006;15:1005–1021.
Feeny D, Furlong W, Boyle M, et al. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics. 1995;7:490–502.
Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40:113–128.
Furlong WJ, Feeny DH, Torrance GW, et al. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33:375–384.
Gulati S, Coughlin PA, Hatfield J, et al. Quality of life in patients with lower limb ischemia; revised suggestions for analysis. J Vasc Surg. 2009;49:122–126.
Hanmer J. Predicting an SF-6D preference-based score using MCS and PCS scores from the SF-12 or SF-36. Value Health. 2009;12:958–966.
Horsman J, Furlong W, Feeny D, et al. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1:54.
Joseph SBS, Elwick H, Silburn R. Adult carers quality of life questionnaire (AC-QoL): development of an evidence-based tool. Mental Health Review Journal. 2012;17:57–69.
Morgan MB, Crayford T, Murrin B, et al. Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg. 2001;33:679–687.
Rand SE, Malley JN, Netten AP, et al. Factor structure and construct validity of the Adult Social Care Outcomes Toolkit for Carers (ASCOT-Carer). Qual Life Res. 2015;24:2601–2614.
Torrance GW, Feeny DH, Furlong WJ, et al. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care. 1996;34:702–722.
Torrance GW, Furlong W, Feeny D, et al. Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics. 1995;7:503–520.
EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208.
WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551–558.
Baram A, Baban ZT. Short and long-term outcomes of the peripheral arterial indirect bypass in diabetic patients with chronic limb-threatening ischemia: Single-center case series. Int J Surg Open. 2020;27:72–78.
Bergner M, Bobbitt RA, Carter WB, et al. The sickness impact profile: development and final revision of a health status measure. Med Care. 1981;19:787–805.
Gilson BS, Gilson JS, Bergner M, et al. The sickness impact profile. Development of an outcome measure of health care. Am J Public Health. 1975;65:1304–1310.
Hardt J. A new questionnaire for measuring quality of life - the Stark QoL. Health Qual Life Outcomes. 2015;13:174.
Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–1736.
Hunt SM, McEwen J. The development of a subjective health indicator. Sociol Health Illn. 1980;2:231–246.
Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract. 1985;35:185–188.
Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337–343.
Rosser R, Kind P. A scale of valuations of states of illness: is there a social consensus? Int J Epidemiol. 1978;7:347–358.
Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001;33:328–336.
Spitzer WO, Dobson AJ, Hall J, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis. 1981;34:585–597.
Ware J Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233.
Ware JKM, Dewey J, Gandek B. How to Score and Interpret Single-Item Health Status Measures: A Manual for Users of the SF-8 Health Survey. Boston: Quality Metric,; 2001.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483.
Poku E, Duncan R, Keetharuth A, et al. Patient-reported outcome measures in patients with peripheral arterial disease: a systematic review of psychometric properties. Health Qual Life Outcomes. 2016;14:161.
Bowling A. Mode of questionnaire administration can have serious effects on data quality. J Public Health (Oxf). 2005;27:281–291.
Stover AM, McLeod LD, Langer MM, et al. State of the psychometric methods: patient-reported outcome measure development and refinement using item response theory. J Patient Rep Outcomes. 2019;3:50.
Australian Bureau of Statistics. Disability, Ageing and Carers. Australia: Summary of Findings; 2015. Available at https://www.abs.gov.au/statistics/health/disability/disability-ageing-and-carers-australia-summary-findings/latest-release#carers Accessed May 20, 2021.
Talley RC, Crews JE. Framing the public health of caregiving. Am J Public Health. 2007;97:224–228.
Thomas GP, Saunders CL, Roland MO, et al. Informal carers’ health-related quality of life and patient experience in primary care: evidence from 195,364 carers in England responding to a national survey. BMC Fam Pract. 2015;16:62.
Alabi O, Roos M, Landry G, et al. Quality-of-life assessment as an outcomes measure in critical limb ischemia. J Vasc Surg. 2017;65:571–578.
Wohlgemuth WA, Olbricht W, Klarmann S, et al. Disease-specific questionnaire for quality of life in patients with peripheral arterial occlusive disease in the stage of critical ischemia (FLeQKI)—methodical development of a specific measuring instrument and psychometric evaluation of its validity and reliability (part 1). Rofo. 2007;179:1251–1257.
Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27:1147–1157.